Cell-based assays have become increasingly important in the preclinical studies for biopharmaceutical products such as specialty peptides, which are of interest owing to their high substrate ...

N-protein glycosylation is a post-translational modification that is conserved in all domains of life 1,2,3,4,5,6,7. The addition of a glycan to a protein can profoundly affect its structure, function ...

Investigation of pegargiminase targeting the Fanconi anemia pathway and its role in DNA double-strand breaks induced by melphalan in uveal melanoma.

Matter Bio, a biotechnology company developing next-generation immunotherapies for difficult-to-treat cancers, today announced that the U.S. Food and Drug Administration has cleared the Company's ...

Matter Bio has submitted its first IND application to the FDA for Lm-LLO-TT, the company’s lead therapeutic candidate, seeking to initiate a first-in-human phase I/IIa trial in patients with ...